JPWO2020001644A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020001644A5
JPWO2020001644A5 JP2020572806A JP2020572806A JPWO2020001644A5 JP WO2020001644 A5 JPWO2020001644 A5 JP WO2020001644A5 JP 2020572806 A JP2020572806 A JP 2020572806A JP 2020572806 A JP2020572806 A JP 2020572806A JP WO2020001644 A5 JPWO2020001644 A5 JP WO2020001644A5
Authority
JP
Japan
Prior art keywords
diacid
mannurone
total weight
pharmaceutical composition
oligosaccharide composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020572806A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021528459A5 (https=
JP2021528459A (ja
Publication date
Priority claimed from CN201810721304.5A external-priority patent/CN110652526A/zh
Application filed filed Critical
Publication of JP2021528459A publication Critical patent/JP2021528459A/ja
Publication of JP2021528459A5 publication Critical patent/JP2021528459A5/ja
Publication of JPWO2020001644A5 publication Critical patent/JPWO2020001644A5/ja
Pending legal-status Critical Current

Links

JP2020572806A 2018-06-29 2019-06-28 糖尿病の治療におけるマンヌロン二酸組成物の使用 Pending JP2021528459A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810721304.5 2018-06-29
CN201810721304.5A CN110652526A (zh) 2018-06-29 2018-06-29 甘露糖醛二酸的组合物在治疗糖尿病中的应用
PCT/CN2019/093822 WO2020001644A1 (zh) 2018-06-29 2019-06-28 甘露糖醛二酸的组合物在治疗糖尿病中的应用

Publications (3)

Publication Number Publication Date
JP2021528459A JP2021528459A (ja) 2021-10-21
JP2021528459A5 JP2021528459A5 (https=) 2022-07-04
JPWO2020001644A5 true JPWO2020001644A5 (https=) 2022-07-04

Family

ID=68985883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020572806A Pending JP2021528459A (ja) 2018-06-29 2019-06-28 糖尿病の治療におけるマンヌロン二酸組成物の使用

Country Status (7)

Country Link
US (1) US11406652B2 (https=)
EP (1) EP3815690A4 (https=)
JP (1) JP2021528459A (https=)
KR (1) KR20210038875A (https=)
CN (1) CN110652526A (https=)
AU (1) AU2019296855A1 (https=)
WO (1) WO2020001644A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112336742A (zh) * 2019-08-06 2021-02-09 上海绿谷制药有限公司 甘露糖醛酸寡糖治疗Th1主导相关疾病的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100501584B1 (ko) 2000-02-03 2005-07-18 (주)케이비피 저분자 폴리만유로네이트의 제조방법, 혈청지질개선제로서의 이의 신규 용도 및 이를 함유하는 기능성식품 및 건강 보조 식품
CN1562050A (zh) * 2004-03-24 2005-01-12 中国海洋大学 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
CN100508985C (zh) * 2004-03-24 2009-07-08 中国海洋大学 褐藻胶寡糖及其衍生物及其制备方法和用途
CN101889027B (zh) 2007-12-29 2013-05-01 于传兴 低分子量海藻酸及其盐、应用、制法及药物组合物、食品
KR20160116252A (ko) 2015-03-27 2016-10-07 전남대학교산학협력단 비환원성 말단의 불포화형 만뉴론산 올리고당 및 이를 유효성분으로 포함하는 조성물
PL3498722T3 (pl) * 2016-08-15 2021-09-20 Shanghai Green Valley Pharmaceutical Co., Ltd. Sposób przygotowania oligomerycznego dikwasu mannuronowego
JP6977059B2 (ja) * 2016-12-30 2021-12-08 シャンハイ、グリーン、バレー、ファーマスーティカル、カンパニー、リミテッドShanghai Green Valley Pharmaceutical Co., Ltd. マンヌロン二酸の組成物

Similar Documents

Publication Publication Date Title
JP6214750B2 (ja) 低用量トピラメート/フェンテルミン組成物およびその使用方法
CA2419993C (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations
AU2003260279B2 (en) Combination of beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
CN1100329A (zh) 具有放射诊断用途的含有用途作x-射线对比介质的碘化芳香化合物的可注射含水配方
EP2034956B2 (en) Compositions comprising glycosaminoglycans of low viscosity and use of said composition in therapy of chronic cystitis
JP2012516358A5 (https=)
JP5781152B2 (ja) アセトアミノフェン組成物
KR20090064597A (ko) 안정화된 프로스타글란딘 e 조성물
JP2021529195A5 (https=)
JP2005187407A (ja) アレルギー眼疾患用眼科組成物
CN101621997B (zh) 医药组合物
CN1132070A (zh) 药用的水悬浮液制剂
JPWO2020001644A5 (https=)
JP2021528459A5 (https=)
JP2021528460A5 (https=)
JPWO2020001640A5 (https=)
JPWO2020001643A5 (https=)
JPWO2020001611A5 (https=)
JP2021528458A5 (https=)
JP2000038342A (ja) 褥瘡・損傷皮膚修復用製剤
JP2004528364A5 (https=)
US20060058261A1 (en) Chitin derivatives for hyperlipidemia
CN111936119B (zh) 甲状腺激素在软胶囊中的高度稳定制剂
CN1780824A (zh) 预防和治疗内毒素相关疾病和病症的组合物和方法
JP2021529196A5 (https=)